Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complementary and alternative medicine and multiple sclerosis.

Neurologic clinics·2011
Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)·2026
Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)·2026
Same journal

Erratum.

Continuum (Minneapolis, Minn.)·2026
Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)·2026
Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)·2026
Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)·2026
See all related articles

Related Experiment Video

Updated: May 20, 2026

Warm Moxibustion and Scraping as a Traditional Chinese Medicine Therapy for Cervical Spondylosis Treatment
04:28

Warm Moxibustion and Scraping as a Traditional Chinese Medicine Therapy for Cervical Spondylosis Treatment

Published on: June 27, 2025

Complementary and alternative medicine in multiple sclerosis.

Allen C Bowling

    Continuum (Minneapolis, Minn.)
    |July 20, 2012
    PubMed
    Summary
    This summary is machine-generated.

    Many multiple sclerosis (MS) patients use complementary and alternative medicine (CAM). Discussing CAM risks and benefits with healthcare providers can improve patient care and safety.

    More Related Videos

    Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis
    08:48

    Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis

    Published on: January 29, 2016

    Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
    06:19

    Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

    Published on: September 9, 2022

    Related Experiment Videos

    Last Updated: May 20, 2026

    Warm Moxibustion and Scraping as a Traditional Chinese Medicine Therapy for Cervical Spondylosis Treatment
    04:28

    Warm Moxibustion and Scraping as a Traditional Chinese Medicine Therapy for Cervical Spondylosis Treatment

    Published on: June 27, 2025

    Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis
    08:48

    Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis

    Published on: January 29, 2016

    Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
    06:19

    Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

    Published on: September 9, 2022

    Area of Science:

    • Neurology
    • Integrative Medicine

    Background:

    • Complementary and alternative medicine (CAM) is widely used by patients with multiple sclerosis (MS).
    • CAM therapies are not always discussed during conventional medical appointments.
    • CAM therapies possess diverse risk-benefit profiles for MS patients.

    Purpose of the Study:

    • To review the risk-benefit profiles of various CAM therapies used by MS patients.
    • To highlight the importance of discussing CAM with healthcare providers.

    Main Methods:

    • Literature review of CAM therapies in the context of multiple sclerosis.
    • Analysis of reported risks and benefits for individual CAM modalities.

    Main Results:

    • Some CAM therapies (e.g., acupuncture, vitamin D, tai chi, yoga) appear low-risk and potentially beneficial for MS.
    • Other CAM therapies (e.g., immune-stimulating supplements, bee venom, hyperbaric oxygen) may be ineffective, dangerous, or lack sufficient study.
    • Significant variability exists in the safety and efficacy of CAM for MS.

    Conclusions:

    • Informed discussion of CAM risks and benefits is crucial for optimizing care in multiple sclerosis.
    • Healthcare providers should proactively engage patients in conversations about their CAM usage.
    • Providing evidence-based information on CAM can enhance patient safety and quality of care for MS.